awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44828253-033B7C43-C1B5-403E-9DE8-5329B6583C21
Q44828253-033B7C43-C1B5-403E-9DE8-5329B6583C21
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44828253-033B7C43-C1B5-403E-9DE8-5329B6583C21
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.
P2860
Q44828253-033B7C43-C1B5-403E-9DE8-5329B6583C21
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44828253-033B7C43-C1B5-403E-9DE8-5329B6583C21
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f174f00e1d6c5a2268e5b308f310a38a0ad03a4
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.